polyethylene glycol 400 0.004 MG/MG / propylene glycol 0.003 MG/MG Ophthalmic Gel
RxNorm concept 895753, clinical drug (scd). Prescribable name: polyethylene glycol 400 0.4 % / propylene glycol 0.3 % Ophthalmic Gel.
- RxCUI
- 895753
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/895753 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
polyethylene glycol 400 0.4 % / propylene glycol 0.3 % Ophthalmic Gel
Related concepts
- polyethylene glycol 400 0.004 MG/MG (SCDC, consists of)
- propylene glycol 0.003 MG/MG (SCDC, consists of)
- {1 (10 ML) (polyethylene glycol 400 0.004 MG/MG / propylene glycol 0.003 MG/MG Ophthalmic Gel) / 1 (10 ML) (polyethylene glycol 400 4 MG/ML / propylene glycol 3 MG/ML Ophthalmic Solution) } Pack (GPCK, contained in)
- Ophthalmic Gel (DF, has dose form)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 895753 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/895753 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 895753. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.